S.Amdt. 97

SA 97. Mr. BLUMENTHAL (for himself and Ms. Klobuchar) submitted an
amendment intended to be proposed by him to the concurrent resolution
S. Con. Res. 3, setting forth the congressional budget for the United
States Government for fiscal year 2017 and setting forth the
appropriate budgetary levels for fiscal years 2018 through 2026; which
was ordered to lie on the table; as follows:

At the end of title III, add the following:

SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO IMPROVING
DRUG PRICING TRANSPARENCY FOR CONSUMERS.

The Chairman of the Committee on the Budget of the Senate
may revise the allocations of a committee or committees,
aggregates, and other appropriate levels in this resolution
for one or more bills, joint resolutions, amendments,
amendments between the Houses, motions, or conference reports
relating to improving drug pricing transparency for consumers
by the amounts provided in such legislation for those
purposes, provided that such legislation would not increase
the deficit over either the period of the total of fiscal
years 2017 through 2021 or the period of the total of fiscal
years 2017 through 2026.
______